Ann F Chambers Selected Research

Ann F Chambers Research Topics

Disease

62	Neoplasms (Cancer) 01/2020 - 04/2002
44	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2002
40	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2002
9	Carcinoma (Carcinomatosis) 01/2020 - 08/2002
7	Brain Neoplasms (Brain Tumor) 06/2018 - 01/2007
6	Lymphatic Metastasis 12/2014 - 06/2006
5	Melanoma (Melanoma, Malignant) 03/2011 - 01/2007
3	Carcinogenesis 01/2020 - 01/2004
3	Colonic Neoplasms (Colon Cancer) 10/2003 - 04/2002
2	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 05/2009
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2016 - 09/2014
2	Ovarian Neoplasms (Ovarian Cancer) 02/2012 - 01/2006
2	Disease Progression 02/2012 - 01/2008
2	Neoplasm Micrometastasis 07/2011 - 10/2003
1	Triple Negative Breast Neoplasms 01/2018
1	Pathologic Complete Response 11/2017
1	Hypoxia (Hypoxemia) 09/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2014
1	Lung Injury 05/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2011
1	Liver Diseases (Liver Disease) 03/2011
1	Experimental Melanoma 01/2009
1	Hemorrhage 01/2009

Drug/Important Bio-Agent (IBA)

33	OsteopontinIBA 01/2020 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 12/2014 - 01/2002
12	IntegrinsIBA 12/2014 - 04/2002
8	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2004
6	Biological ProductsIBA 12/2011 - 02/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2005
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2003
4	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2005
4	PhosphoproteinsIBA 01/2020 - 09/2003
4	Tumor Biomarkers (Tumor Markers)IBA 06/2011 - 04/2002
4	Carrier Proteins (Binding Protein)IBA 07/2006 - 04/2002
3	LigandsIBA 01/2018 - 09/2003
3	IronIBA 10/2017 - 01/2007
3	Pharmaceutical PreparationsIBA 06/2016 - 07/2009
3	Messenger RNA (mRNA)IBA 08/2008 - 01/2005
2	Estrogen ReceptorsIBA 01/2018 - 01/2007
2	Cisplatin (Platino)FDA LinkGeneric 02/2015 - 12/2014
2	Hormones (Hormone)IBA 01/2014 - 08/2002
2	Glycoproteins (Glycoprotein)IBA 01/2014 - 01/2008
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2012 - 08/2011
2	SERPIN-B5 (maspin)IBA 02/2012 - 08/2011
2	ferric oxide (iron oxide)IBA 07/2011 - 11/2009
2	Small Interfering RNA (siRNA)IBA 07/2011 - 01/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2009 - 12/2003
2	Indicators and Reagents (Reagents)IBA 05/2009 - 05/2005
2	Peptide Hydrolases (Proteases)FDA Link 01/2009 - 11/2007
2	GenisteinIBA 01/2009 - 04/2005
2	Cell Surface ReceptorsIBA 11/2007 - 01/2005
2	OligonucleotidesIBA 08/2005 - 04/2002
1	Thymine DNA GlycosylaseIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	matrigelIBA 01/2016
1	GasotransmittersIBA 09/2015
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2015
1	TenascinIBA 12/2014
1	Cyclin A2IBA 12/2014
1	Antisense OligonucleotidesIBA 12/2014
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2014
1	CortactinIBA 09/2014
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2014
1	Tamoxifen FDA LinkGeneric 01/2014
1	neuropeptide Y5 receptorIBA 07/2012
1	Neuropeptide YIBA 07/2012
1	SerpinsIBA 02/2012
1	Cadherins (E-Cadherin)IBA 01/2012
1	Vascular Endothelial Growth Factor CIBA 01/2012
1	Vascular Endothelial Growth Factor DIBA 01/2012
1	JSM6427IBA 12/2011
1	volociximabIBA 12/2011
1	AntibodiesIBA 12/2011
1	acetyl- prolyl- histidyl- seryl- cysteinyl- asparaginamideIBA 12/2011
1	Gadolinium DTPA (Magnevist)FDA Link 11/2011
1	src-Family KinasesIBA 10/2011
1	Nuclear Export Signals (Nuclear Export Signal)IBA 08/2011
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 03/2011
1	imidazoleIBA 03/2011
1	TriterpenesIBA 03/2011
1	bardoxoloneIBA 03/2011
1	Aprotinin (Trasylol)FDA Link 01/2009
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2009
1	Fibrinolysin FDA Link 01/2009
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2009

Therapy/Procedure

23	Therapeutics 01/2018 - 08/2002
5	Radiotherapy 06/2018 - 08/2002
3	Aftercare (After-Treatment) 06/2018 - 04/2002
3	Neoadjuvant Therapy 11/2017 - 05/2014
3	Drug Therapy (Chemotherapy) 11/2017 - 12/2003
2	Castration 02/2016 - 05/2009
2	Injections 01/2008 - 04/2002
1	Cranial Irradiation 10/2017
1	Prostatectomy (Retropubic Prostatectomy) 02/2016
1	Heterologous Transplantation (Xenotransplantation) 12/2014
1	Oral Administration 03/2011
1	Immunotherapy 01/2009